Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Johnson & Johnson Innovative Medicine |
U.S.A |
KURA ONCOLOGY INC | 17517 | TIPIFARNIB (R115777) DRUG SUBSTANCE | 2004-07-14 | Active | II | N/A |
